about
Morphogenetic fields in embryogenesis, regeneration, and cancer: non-local control of complex patterningThiopurine use associated with reduced B and natural killer cells in inflammatory bowel diseaseEffectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitroEssential oils and their constituents as anticancer agents: a mechanistic view.Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.A robust and versatile signal-on fluorescence sensing strategy based on SYBR Green I dye and graphene oxide.Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study.Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistanceImproved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.Tumor markers in ovarian carcinoma.Lipid rafts: dream or reality for cholesterol transporters?Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse.Cytotoxicity of the Roots of Trillium govanianum Against Breast (MCF7), Liver (HepG2), Lung (A549) and Urinary Bladder (EJ138) Carcinoma Cells.Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.Topoisomerase I inhibitors and drug resistanceP-glycoprotein: clinical significance and methods of analysis.Regulation of protein kinase C and role in cancer biology.Inhibition of tumor-associated fatty acid synthase hyperactivity induces synergistic chemosensitization of HER -2/ neu -overexpressing human breast cancer cells to docetaxel (taxotere).Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.Circumvention of chemotherapy-induced myelosuppression by transfer of the mdr1 gene.Etoposide: current status and future perspectives in the management of malignant neoplasms.Cellular models for multiple drug resistance in cancer.Multidrug resistance gene 1 expression in salivary gland adenocarcinomas and oral squamous-cell carcinomas.Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy.Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment.Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity.Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.Circumvention of confluence-dependent resistance in a human multi-drug-resistant colon-cancer cell line.Characterization and chemosensitivity of a human epithelioid sarcoma cell line (SARCCR 2).Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues.Membrane transport proteins associated with drug resistance expressed in human melanomaATP and GTP as alternative energy sources for vinblastine transport by P-170 in KB-V1 plasma membrane vesicles.Pilot study: duodenal MDR1 and COX2 gene expression in cats with inflammatory bowel disease and low-grade alimentary lymphoma.P-glycoprotein expression in de novo acute myeloid leukemia.Clinical study of multi-drug resistance gene (MDR1) expression in primary ovarian cancer.High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia.
P2860
Q27023511-6128D913-0957-41EE-A870-CCBFF82C5E85Q33696379-2B028927-AF35-4584-8A6C-5E0F900EFB90Q33744180-59EC7AC8-4F80-4E7E-8D8C-9E87B6726EBCQ33805315-76625AC3-32D4-45FC-816E-94FE16773A8BQ34710990-E8C37BA6-7417-468A-AF23-DBACCE50C05AQ34783705-369C9183-A76A-4D08-85E2-D74E9AFBFEB2Q35796217-9607537C-B6BA-465D-A0D9-E6EB6B218B7AQ35821659-053A450F-967A-4631-A6CE-90A8BBDD0679Q35975758-82B560EC-220D-465B-8E27-857E1B53FB42Q36079469-4539AEBC-B5E4-4339-AFCE-F9D4BDDDD54DQ36136242-BE89D7A5-307F-4DCA-9C3D-C62B2E2F0356Q36674507-2B5550AC-16B8-47C2-83D7-8294C357EC3BQ36767181-C5A4FAF8-5B75-4E36-A2AC-C73824CE9089Q36852328-B4E5C337-2904-40CD-85F3-745C7F3CCDE8Q37575786-B4994F3B-44A1-4EE0-BC12-482D61B0A223Q39641590-46CC599D-FEBF-437D-9858-1690309E77AAQ39998933-2CFB49E0-6073-4694-8BD7-0351E5D74E18Q40028536-C1E1F855-0253-4C45-A42C-4EA2E3968CD2Q40380366-DA9A4226-0EAD-4B4E-A779-9A7AFD2C2687Q40504332-A404418C-D67A-4625-B9B9-87672121570CQ40582648-53FEC0F5-54C7-4DCD-8579-124E6122AEA9Q40618716-7D431018-197B-4140-8C18-F6BDD1201FCEQ40620465-9EEB5B1E-B469-4187-A4B9-A0E0909AF368Q40623933-D36891B7-429E-478A-9D23-6290C4D1E45AQ40694333-FC1A6E97-6E0C-455A-B408-B60E54002F72Q40708934-67E791A0-32EE-4006-A0E6-3A43E40B8699Q40814277-E65E1FA1-EB93-41FE-AFE6-9FC053B3DB3CQ40931773-5E3DEBD2-8202-4859-89DA-51B9A2A389E0Q41110046-89291A01-73CB-4C39-847E-8E3E9E2501BBQ41120824-E86EA420-7ACB-4F90-ACC6-1C250237E96AQ41184566-1FA6838B-D629-48DB-BCAF-B6F0EE6C3A28Q41335561-2EFCF7C4-8BEB-49E8-887C-CBDC48BF8C51Q41547164-43626910-2E0C-4949-A4ED-070DFE22C898Q42525924-5BB347F9-ECC9-435C-B4C8-27B05D065AC2Q42789387-7848ED2B-376D-4D9A-B5A5-DC12BEF952E1Q46403272-3D607DDE-6DCF-4D1A-82B7-9D06720ECD94Q47742647-E2B5B2CB-161B-4468-ACE9-CF9B0526C35DQ50918570-09D0AE42-7204-4661-920D-0612DB707B4EQ54051884-A07C1088-45CC-402C-B73D-EB7D590317EFQ54194573-91FC39F5-EE2F-4B5D-8406-3472C9E900A8
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Multidrug resistance (mdr) genes in human cancer.
@ast
Multidrug resistance (mdr) genes in human cancer.
@en
type
label
Multidrug resistance (mdr) genes in human cancer.
@ast
Multidrug resistance (mdr) genes in human cancer.
@en
prefLabel
Multidrug resistance (mdr) genes in human cancer.
@ast
Multidrug resistance (mdr) genes in human cancer.
@en
P2860
P921
P356
P1476
Multidrug resistance (mdr) genes in human cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1991.152
P407
P577
1991-05-01T00:00:00Z